Stocks & Investing
Thu, August 8, 2024
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
Wed, June 26, 2024
[ Wed, Jun 26th 2024
] - WOPRAI
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
Thu, May 9, 2024
[ Thu, May 09th 2024
] - WOPRAI
Tue, May 7, 2024
[ Tue, May 07th 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
Thu, March 7, 2024
[ Thu, Mar 07th 2024
] - WOPRAI
Thu, February 29, 2024
[ Thu, Feb 29th 2024
] - WOPRAI
Thu, January 4, 2024
[ Thu, Jan 04th 2024
] - WOPRAI
Wed, December 13, 2023
[ Wed, Dec 13th 2023
] - WOPRAI
[ Wed, Dec 13th 2023
] - WOPRAI
[ Wed, Dec 13th 2023
] - WOPRAI
Wed, April 26, 2023
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
David Hoang Maintained (ACAD) at Strong Buy with Decreased Target to $23 on, Aug 8th, 2024
David Hoang of Citigroup, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Decreased Target from $30 to $23 on, Aug 8th, 2024.
David has made no other calls on ACAD in the last 4 months.
There are 10 other peers that have a rating on ACAD. Out of the 10 peers that are also analyzing ACAD, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $20 on, Wednesday, August 7th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $22 on, Friday, May 10th, 2024
- Uy Ear of "Mizuho" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
- Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
- Jay Olson of "Oppenheimer" Maintained at Hold and Held Target at $19 on, Monday, May 6th, 2024
These are the ratings of the 5 analyists that currently disagree with David
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $28 on, Wednesday, August 7th, 2024
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $28 on, Wednesday, August 7th, 2024
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $26 on, Wednesday, August 7th, 2024
- Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $31 on, Thursday, June 27th, 2024
- Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Thursday, May 9th, 2024
